During the past decade, Universitäts-Augenklinik Heidelberg conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitäts-Augenklinik Heidelberg" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Lux Biosciences, Inc." with 3 trials sponsored, "Beaver-Visitec International, Inc." with 2 trials sponsored, "Okuvision GmbH" with 1 trials sponsored and "Ophtec BV" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitäts-Augenklinik Heidelberg" #1 collaborator was "CONET GmbH - Clinical Operations Network" with 1 trials as a collaborator and "targomedGmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universitäts-Augenklinik Heidelberg" are "Cataract" (4 trials), "Panuveitis" (3 trials), "Geographic Atrophy" (2 trials), "Lens Opacities" (2 trials) and "Presbyopia" (2 trials). Many other conditions were trialed in "Universitäts-Augenklinik Heidelberg" in a lesser frequency.

Most popular intervention types in "Universitäts-Augenklinik Heidelberg" are "Drug" (8 trials), "Device" (6 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "LX211" (3 trials), "Placebo" (3 trials), "Faricimab" (2 trials), "Lampalizumab" (2 trials) and "Sham Procedure" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitäts-Augenklinik Heidelberg" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Universitäts-Augenklinik Heidelberg". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Universitäts-Augenklinik Heidelberg, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universitäts-Augenklinik Heidelberg, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".